The drugmaker is using Propeller Health's sensor technology to find new ways to improve adherence in clinical studies.
IMS and Quintiles to merge and create $17 billion firm; Biogen spins off hemophilia company; Google partners with the National Health Service
Welcome to the mobile era for clinical trials, in which phone and tablet technology promise to upend a costly and unwieldy process.
Proteus and Otsuka seek approval of "digital" drug; J&J moves its US media-buying business back to UM; FDA committee votes no on Purdue's new opioid
The academic partnership builds on the company's 2014 collaboration with UCB on using sensors to gather biometric data about people with neurological disorders.
- BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists
- Five things for pharma marketers to know: Wednesday, December 7, 2016
- Matt Brown leaves Guidemark Health after merger falls through
- Five things for pharma marketers to know: Monday, December 5, 2016
- GSK and Propeller Health's smart inhaler aims to improve adherence in clinical trials
- Omnicom merges AgencyRx, Flashpoint and three other agencies to form DDB Health
- No free lunch for docs: Sponsored meals linked to more prescriptions
- Non-profit behind Free Killer Tan wants parents to practice sun safety
- Allergan draws on A-list celebs to drive engagement
- There's no such thing as gay blood, says campaign from FCB Health